✦ LIBER ✦

Rejection Under Alpha Interferon Therapy in Liver Transplant Recipients

✍ Scribed by T. Walter; J. Dumortier; O. Guillaud; V. Hervieu; P. Paliard; J.-Y. Scoazec; O. Boillot

Book ID: 114804174
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 241 KB
Volume: 7
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2006.01590.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.397 Rejection under interferon alpha t

P.397 Rejection under interferon alpha therapy in liver transplant patients

✍ T. Walter; J. Dumortier; O. Guillaud; J. Scoazec; O. Boillot 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Outcomes of acute rejection after interf

Outcomes of acute rejection after interferon therapy in liver transplant recipients

✍ Sammy Saab; Denise Kalmaz; Nupoor A. Gajjar; Jonathan Hiatt; Francisco Durazo; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease in post-liver transplant (LT) recipients. A serious potential adverse effect is acute rejection. We reviewed our experience using interferonbased therapy (interferon or pegylated interferon with or without ribavir

Interferon-Alpha Therapy in Liver Transp

Interferon-Alpha Therapy in Liver Transplant Recipients: Lack of Association with Increased Production of Anti-HLA Antibodies

✍ Francesca Cardarelli; Manuel Pascual; Raymond T. Chung; Nina Tolkoff-Rubin; Waic 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Anti-lymphocyte therapy successfully con

Anti-lymphocyte therapy successfully controls late “cholestatic” rejection in pediatric liver transplant recipients

✍ N. Kerkar; R. A. Morotti; K. Iyer; R. Arnon; T. Miloh; M. Sturdevant; F. Suchy; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Incidence and severity of acute allograf

Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon

✍ Jain, Ashokkumar ;Demetris, Anthony J. ;Manez, Rafael ;Tsamanadas, Athanassisos 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 195 KB 👁 1 views

Interferon alfa-2b (IFN-alpha) therapy has been shown to be effective in the treatment of viral hepatitis B (HBV) or viral hepatitis C (HCV) in patients who did not undergo transplantation. However, in allograft recipients, treatment with IFN-alpha often leads to allograft rejection. The aim of the

Treatment of chronic hepatitis E in live

Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b

✍ Elizabeth B. Haagsma; Annelies Riezebos-Brilman; Arie P. van den Berg; Robert J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Hepatitis E virus (HEV) infections are known to run a self-limiting course. Recently, chronic hepatitis E has been described in immunosuppressed patients after solid-organ transplantation. Besides the general recommendation to lower the immunosuppressive medication in these patients, there is curren